Daiichi Sankyo: all 498 studies

Page 3 of 5. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.

• Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency AnemiaCompletedNCT00704028Phase 3Results posted
• Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency AnemiaCompletedNCT00703937Phase 3Results posted
• SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00698828Phase 2Results posted
• Intravenous Iron Metabolism in Restless Legs SyndromeCompletedNCT00685815Phase 2Results posted
• Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With OsteoporosisCompletedNCT00680953Phase 3Results posted
• 18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 DiabeticsCompletedNCT00654745Phase 4Results posted
• Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionCompletedNCT00649389Phase 3Results posted
• Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's DiseaseCompletedNCT00623363Phase 2Results posted
• A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With PaclitaxelTerminatedNCT00603941Phase 1/2Results posted
• Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes MellitusTerminatedNCT00571519Phase 3Results posted
• Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.CompletedNCT00570739Phase 3Results posted
• Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum PatientsCompletedNCT00548860Phase 3Results posted
• Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease PatientsCompletedNCT00548691Phase 3Results posted
• Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II HypertensionCompletedNCT00527514Phase 3Results posted
• Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic CancerCompletedNCT00521404Phase 2Results posted
• A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial FibrillationCompletedNCT00504556Phase 2Results posted
• Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With MetforminCompletedNCT00484419Phase 3Results posted
• Study of Rivoglitazone in Type 2 Diabetes MellitusCompletedNCT00484198Phase 3Results posted
• A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 StatusCompletedNCT00462761Phase 1Results posted
• Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionCompletedNCT00430950Phase 3Results posted
• A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II HypertensionCompletedNCT00430638Phase 4Results posted
• Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionCompletedNCT00430508Phase 3Results posted
• An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With HypertensionCompletedNCT00412932Phase 4Results posted
• Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic CancerCompletedNCT00408434Phase 1Results posted
• Safety Study of PLX4032 in Patients With Solid TumorsCompletedNCT00405587Phase 1Results posted
• An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II DiabetesCompletedNCT00403481Phase 4Results posted
• A Study of DU-176b in Preventing Blood Clots After Hip Replacement SurgeryCompletedNCT00398216Phase 2Results posted
• Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum AnemiaCompletedNCT00396292Phase 3Results posted
• Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine BleedingCompletedNCT00395993Phase 3Results posted
• Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum PatientsCompletedNCT00354484Phase 3Results posted
• VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseCompletedNCT00317239Phase 3Results posted
• Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseCompletedNCT00317226Phase 3Results posted
• Olmesartan and an add-on Treatment in Patients With Mild to Moderate HypertensionCompletedNCT00311155Phase 4Results posted
• Taxoprexin Plus Carboplatin Treatment for Advanced Lung CancerCompletedNCT00243867Phase 3Results posted
• Safety and Efficacy of Iron Sucrose in ChildrenCompletedNCT00239642Phase 4Results posted
• Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With AnemiaCompletedNCT00236977Phase 3Results posted
• Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin TherapyCompletedNCT00236951Phase 3Results posted
• Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal DialysisCompletedNCT00236938Phase 3Results posted
• Olmesartan Pediatric Pharmacokinetic (PK) StudyCompletedNCT00151814Phase 1Results posted
• Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood PressureCompletedNCT00151775Phase 2/3Results posted
• Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 DiabetesCompletedNCT00147745Phase 2Results posted
• Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High CholesterolCompletedNCT00145574Phase 4Results posted
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy TrialCompletedNCT00141453Phase 3Results posted
• Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip ReplacementCompletedNCT00107900Phase 2Results posted
• A Real World Evidence Retrospective Data Collection Study of Edoxaban and RivaroxabanCompletedNCT07874555
• Medical Access Program for DS-9606a (DS-9606) in Patients With Advanced Testicular Germ Cell TumorsTemporarily not availableNCT07863284
• Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung CancerNo longer availableNCT07535359
• Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and AtorvastatinCompletedNCT07268625Phase 1
• A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and AtorvastatinCompletedNCT07235189Phase 1
• Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and RosuvastatinCompletedNCT07201545Phase 1
• Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and RosuvastatinCompletedNCT07182383Phase 1
• Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast CancerActive, not recruitingNCT07092254
• Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6iCompletedNCT06975371
• A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in TaiwanCompletedNCT06925113
• A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in TaiwanCompletedNCT06925100Phase 4
• Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab DeruxtecanCompletedNCT06833268
• A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)CompletedNCT06812117
• A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart RateCompletedNCT06772246Phase 1
• Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy SubjectsCompletedNCT06740825Phase 1
• Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) PatientsCompletedNCT06690450Phase 4
• A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed DyslipidemiaActive, not recruitingNCT06686615
• A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast CancerCompletedNCT06686602
• A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)Active, not recruitingNCT06660654Phase 2
• A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic AlterationsActive, not recruitingNCT06644768Phase 1/2
• A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line TreatmentsCompletedNCT06617390
• A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in ChinaCompletedNCT06585501
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AMLActive, not recruitingNCT06578247Phase 3
• Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of TreatmentCompletedNCT06557967
• Real-World Pharmacological Treatment Pattern of Neuropathic Pain in ChinaCompletedNCT06546202
• Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC PatientsApproved for marketingNCT06279728
• A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid TumorsActive, not recruitingNCT06244485Phase 1
• Medical Access Program for Patritumab DeruxtecanNo longer availableNCT06099639
• A Study of DS-1471a In Subjects With Advanced Solid TumorsTerminatedNCT06074705Phase 1
• Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast CancerCompletedNCT06040593
• A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)Active, not recruitingNCT05993234
• A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial FibrillationCompletedNCT05804747
• Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed DyslipidemiaWithdrawnNCT05798390
• A Study of Prevalence of HER3 Expression in Non-Small Cell Lung CancerCompletedNCT05769764
• A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast CancerCompletedNCT05769751
• Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PNWithdrawnNCT05677126Phase 4
• Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese SafetyWithdrawnNCT05661682Phase 4
• Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East AsiaCompletedNCT05606094
• A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy SubjectsCompletedNCT05583669Phase 1
• Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)Active, not recruitingNCT05555732Phase 3
• A Dose Finding Study of VN-0200CompletedNCT05547087Phase 2
• SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to Treat Patients at High and Very High Cardiovascular Risk With hyperchOlesterolemia or Mixed Dyslipidemia With NUSTENDI®CompletedNCT05546398
• EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab DeruxtecanCompletedNCT05458401
• A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseCompletedNCT05400369Phase 4
• A Study of DS-9606a in Patients With Advanced Solid TumorsTerminatedNCT05394675Phase 1
• A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy SubjectsCompletedNCT05388903Phase 1
• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI TherapyActive, not recruitingNCT05338970Phase 3
• Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)Active, not recruitingNCT05280470Phase 2
• Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial FibrillationCompletedNCT05262322
• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic AlterationsActive, not recruitingNCT05215340Phase 3
• A Study of a Single Ascending Dose Study of DS-7011a in Healthy SubjectsCompletedNCT05203692Phase 1
• Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast CancerCompletedNCT05149014
• An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of DyslipidemiaCompletedNCT05120895
• An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 DiabetesCompletedNCT05107063
• Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE SiblingsCompletedNCT05025722
• Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency AnemiaWithdrawnNCT04968379Phase 2

← Daiichi Sankyo overview and focus areas